Literature DB >> 8703526

Community care of patients with schizophrenia: the role of the primary health care team.

M King1, I Nazareth.   

Abstract

Schizophrenia is a severe, chronic mental disorder that usually begins in early adulthood. Recurrent relapse leading to long-term psychological and social disability means that patients may require intensive community support. Despite a recent fall in the overall numbers of patients consulting their general practitioner with mental disorders, presentations by those suffering from severe mental disorders have risen. This review encompasses the role of general practitioner in the management of schizophrenia, considering in turn drug and psychological therapies, family interventions, innovations in care, the effects of community care developments, and the liasion between primary health care and mental health professionals. There is a need for further research in the area of family-practice-based interventions involving general practitioners and the practice team.

Entities:  

Mesh:

Year:  1996        PMID: 8703526      PMCID: PMC1239607     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  64 in total

1.  Care of schizophrenia in general practice.

Authors:  I Nazareth; M King; A Haines; S S Tai; G Hall
Journal:  BMJ       Date:  1993-10-09

2.  Suicide and psychiatric services.

Authors:  G Lewis; L Appleby; B Jarman
Journal:  Lancet       Date:  1994-09-17       Impact factor: 79.321

Review 3.  Understanding the mechanism of action of atypical antipsychotic drugs. A review of compounds in use and development.

Authors:  J A Lieberman
Journal:  Br J Psychiatry Suppl       Date:  1993-12

Review 4.  Conditions predisposing to suicide: a review.

Authors:  C P Miles
Journal:  J Nerv Ment Dis       Date:  1977-04       Impact factor: 2.254

5.  Specialist outreach clinics in general practice.

Authors:  J J Bailey; M E Black; D Wilkin
Journal:  BMJ       Date:  1994-04-23

6.  Clinical psychology in general practice: a controlled trial evaluation.

Authors:  L Earll; J Kincey
Journal:  J R Coll Gen Pract       Date:  1982-01

7.  Effects of a community mental health service on the practice and attitudes of general practitioners.

Authors:  R W Warner; R Gater; M G Jackson; D P Goldberg
Journal:  Br J Gen Pract       Date:  1993-12       Impact factor: 5.386

8.  Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate.

Authors:  N R Schooler; J Levine; J B Severe; B Brauzer; A DiMascio; G L Klerman; V B Tuason
Journal:  Arch Gen Psychiatry       Date:  1980-01

Review 9.  Working with the families of schizophrenic patients.

Authors:  J Leff
Journal:  Br J Psychiatry Suppl       Date:  1994-04

10.  Provision of care to general practice patients with disabling long-term mental illness: a survey in 16 practices.

Authors:  T Kendrick; T Burns; P Freeling; B Sibbald
Journal:  Br J Gen Pract       Date:  1994-07       Impact factor: 5.386

View more
  4 in total

1.  How do general practitioners manage subjects with early schizophrenia and collaborate with mental health professionals? A postal survey in South-Western France.

Authors:  Hélène Verdoux; Audrey Cougnard; Sabrina Grolleau; Rachel Besson; Françoise Delcroix
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-10-08       Impact factor: 4.328

2.  Workload implications of community psychiatric nurse employment by a general practice: a pilot study.

Authors:  J Bruce; M S Watson; D Watson; A N Palin; K Lawton
Journal:  Br J Gen Pract       Date:  1998-07       Impact factor: 5.386

Review 3.  Schizophrenia in black Caribbeans living in the UK: an exploration of underlying causes of the high incidence rate.

Authors:  Rebecca Pinto; Mark Ashworth; Roger Jones
Journal:  Br J Gen Pract       Date:  2008-06       Impact factor: 5.386

4.  A study of profile of disability certificate seeking patients with schizophrenia over a 5 year period.

Authors:  Yatan Pal Singh Balhara; Rohit Verma; Smita N Deshpande
Journal:  Indian J Psychol Med       Date:  2013-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.